Walgreens Boots Alliance, the owner of pharmacy retailer Boots UK, has reported a strong showing in its third financial quarter, as operating income from continuing operations totalled at $1.1bn (£799m) over the period.
In comparison, the group posted a significant loss of $1.7bn (£1.2bn) over the same period a year ago.
Furthermore, adjusted operating income from continuing operations increased by 82.9% on a reported currency basis to $1.5bn (£1bn), with sales from continuing operations rising by 12.1% to $34bn (£24.7bn)
Boots UK’ s comparable pharmacy sales increased 3.7% over the period, with retail sales jumping 38.7% thanks to strong footfall following lockdown.
Rosalind Brewer, the group’s chief executive, said: “This quarter’s results demonstrate continued momentum, and while challenges lie ahead, we are in a strong position to grow and innovate our core retail and pharmacy businesses for the future.
“We are accelerating our investments to advance our operational excellence, including technology innovations that support mass personalization, pharmacy of the future and the next phase of growth in tech-enabled healthcare.”
She added: “These investments are fueled by our Alliance Healthcare divestiture. I remain proud of our team members and the essential role they are playing to help end the pandemic as the communities we serve continue to turn to our trusted brands and expert pharmacists.”